PRESS RELEASE
Oslo, Norway – 13 June 2023
Sustainable biochemicals company Circa Group AS (stock symbol: CIRCA) welcomes Dr Alessandro Napoli as VP Product Development, commencing September 2023.
Joining the Circa leadership team, Alessandro’s responsibilities include development of levoglucosenone derivatives as well as optimizing process chemistry for the ReSolute and FC6 manufacturing operations.
Following a PhD in materials science from ETH Zurich and post doc work including biomaterials, Dr Napoli has held management roles with Huntsman Corporation in Europe involving both opportunity identification and development including most recently leading the New Material Platforms Team.
Tony Duncan, CEO of Circa Group AS, said, “Alessandro is an important addition to Circa’s expert resources. As a platform molecule, levoglucosenone can be developed into a wide range of new, lower carbon high performance chemicals for different applications, and Alessandro brings a strong commercial focus to innovation that will greatly benefit Circa’s product development timelines.”
“I am excited for the opportunity to join Circa and contribute to realising the potential that sustainable chemicals have to transform the chemical industry. Further developing the performance and uniqueness of levoglucosenone and its derivatives will strengthen Circa’s innovation pipeline” says Dr Alessandro Napoli.